Per ulteriori informazioni selezionare i riferimenti di interesse.
Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's - Associated adenocarcinoma
JOURNAL OF GASTROINTESTINAL SURGERY
Epidermal growth factor receptor and HER2-neu mRNA expression in non-smallcell lung cancer is correlated with survival
CLINICAL CANCER RESEARCH
Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the national cancer institute's anticancer drugscreen
CLINICAL CANCER RESEARCH
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival
ONCOGENE
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectalcancer patients receiving combination oxaliplatin and fluorouracil chemotherapy
JOURNAL OF CLINICAL ONCOLOGY
Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence
SURGERY
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma
JOURNAL OF SURGICAL RESEARCH
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence
JOURNAL OF GASTROINTESTINAL SURGERY
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
CLINICAL CANCER RESEARCH
Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Molecular marker as the basis for chemotherapy?
CHIRURG
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylatesynthase
CANCER RESEARCH
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma
CANCER RESEARCH
Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable livertumors receiving hepatic arterial infusion chemotherapy
CANCER
Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression ofalpha and beta tubulin isoforms
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma
JOURNAL OF THE NATIONAL CANCER INSTITUTE
Rapid activation of MDR1 gene expression in human metastatic sarcoma afterin vivo exposure to doxorubicin
CLINICAL CANCER RESEARCH
Concurrent paclitaxel and radiation therapy for breast cancer
SEMINARS IN RADIATION ONCOLOGY
Thymidylate synthase inhibitors
SEMINARS IN ONCOLOGY
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. (vol 59, pg 2302, 1999)
CANCER RESEARCH
Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes
CANCER RESEARCH
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression
CANCER RESEARCH
DESENSITIZATION AND SENSITIZATION OF CELLS TO FLUOROPYRIMIDINES WITH DIFFERENT ANTISENSES DIRECTED AGAINST THYMIDYLATE SYNTHASE MESSENGER-RNA
Clinical cancer research
P53 AND THYMIDYLATE SYNTHASE EXPRESSION IN UNTREATED STAGE-II COLON-CANCER - ASSOCIATIONS WITH RECURRENCE, SURVIVAL, AND SITE
Clinical cancer research
P53 AND THYMIDYLATE SYNTHASE EXPRESSION IN UNTREATED STAGE-II COLON-CANCER - ASSOCIATIONS WITH RECURRENCE, SURVIVAL, AND SITE
Clinical cancer research
P53 POINT MUTATIONS AND THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN DISSEMINATED COLORECTAL-CANCER - AN ANALYSIS OF RESPONSE AND SURVIVAL
Clinical cancer research
P53 POINT MUTATIONS AND THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN DISSEMINATED COLORECTAL-CANCER - AN ANALYSIS OF RESPONSE AND SURVIVAL
Clinical cancer research
RESTORATION OF WILD-TYPE P53 ACTIVITY IN P53-NULL HL-60 CELLS CONFERSMULTIDRUG SENSITIVITY
Clinical cancer research
RESTORATION OF WILD-TYPE P53 ACTIVITY IN P53-NULL HL-60 CELLS CONFERSMULTIDRUG SENSITIVITY
Clinical cancer research
HIGH BASAL LEVEL GENE-EXPRESSION OF THYMIDINE PHOSPHORYLASE (PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR) IN COLORECTAL TUMORS IS ASSOCIATED WITH NONRESPONSE TO 5-FLUOROURACIL
Clinical cancer research
A PHARMACODYNAMIC STUDY OF RALTITREXED (TOMUDEX(R)) IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - PREDICTORS OF RESPONSE AND TOXICITY
Annals of oncology
HIGHER LEVELS OF THYMIDYLATE SYNTHASE GENE-EXPRESSION ARE OBSERVED INPULMONARY AS COMPARED WITH HEPATIC METASTASES OF COLORECTAL ADENOCARCINOMA
Journal of clinical oncology
ERCC1 MESSENGER-RNA LEVELS COMPLEMENT THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN PREDICTING RESPONSE AND SURVIVAL FOR GASTRIC-CANCER PATIENTS RECEIVING COMBINATION CISPLATIN AND FLUOROURACIL CHEMOTHERAPY
Journal of clinical oncology
HIGH-FREQUENCY OF SIMULTANEOUS LOSS OF P16 AND P16-BETA GENE-EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS BUT NOT IN ADENOCARCINOMA OF THE ESOPHAGUS OR STOMACH
Oncogene
QUANTITATION OF INTRATUMORAL THYMIDYLATE SYNTHASE EXPRESSION PREDICTSFOR DISSEMINATED COLORECTAL-CANCER RESPONSE AND RESISTANCE TO PROTRACTED-INFUSION FLUOROURACIL AND WEEKLY LEUCOVORIN
Journal of clinical oncology
THYMIDYLATE SYNTHASE IS A PREDICTOR FOR RESPONSE AND RESISTANCE IN HEPATIC-ARTERY INFUSION CHEMOTHERAPY
Cancer letters
THYMIDYLATE SYNTHASE MESSENGER-RNA LEVEL IN ADENOCARCINOMA OF THE STOMACH - A PREDICTOR FOR PRIMARY TUMOR RESPONSE AND OVERALL SURVIVAL
Journal of clinical oncology
RAPID QUANTITATIVE PCR FOR DETERMINATION OF RELATIVE GENE EXPRESSIONSIN TISSUE SPECIMENS
PCR methods and applications
RETINOBLASTOMA GENE MUTATION IN PRIMARY HUMAN RENAL-CELL CARCINOMA
Oncology research
IDENTIFICATION OF MUTATIONS BY RNA CONFORMATIONAL POLYMORPHISM BAR CODE ANALYSIS
Genomics
TUMOR-SUPPRESSOR GENE P53 MUTATIONS IN HUMAN PROSTATE-CANCER
The Prostate
GENE AMPLIFICATION AND MULTIDRUG-RESISTANCE INDUCED BY THE PHOSPHATASE-INHIBITORY TUMOR PROMOTER, OKADAIC ACID
Carcinogenesis
EFFECT OF 5-FLUOROURACIL AND 5-BROMOURACIL SUBSTITUTION ON THE TRANSLATION OF HUMAN THYMIDYLATE SYNTHASE MESSENGER-RNA (VOL 269, PG 16269, 1194)
The Journal of biological chemistry
THYMIDYLATE SYNTHASE GENE AND PROTEIN EXPRESSION CORRELATE AND ARE ASSOCIATED WITH RESPONSE TO 5-FLUOROURACIL IN HUMAN COLORECTAL AND GASTRIC TUMORS
Cancer research
QUANTITATIVE-ANALYSIS OF FOLYLPOLYGLUTAMATE SYNTHETASE GENE-EXPRESSION IN TUMOR-TISSUES BY THE POLYMERASE CHAIN-REACTION - MARKED VARIATIONOF EXPRESSION AMONG LEUKEMIA PATIENTS
Oncology research
MOLECULAR-DETECTION AND CHARACTERIZATION OF CLONAL CELL-POPULATIONS IN ACUTE LYMPHOCYTIC-LEUKEMIA BY ANALYSIS OF CONFORMATIONAL POLYMORPHISMS OF CRNA MOLECULES OF REARRANGED T-CELL-RECEPTOR-GAMMA AND IMMUNOGLOBULIN HEAVY-CHAIN GENES
Leukemia
QUANTITATIVE-DETERMINATION OF THE RATIO OF MUTATED TO NORMAL RAS GENES IN THE BLOOD OF LEUKEMIA PATIENTS BY ALLELE-SPECIFIC PCR
Leukemia research
INCORPORATION OF 5-FLUOROURACIL INTO U2 AND U6 SNRNA INHIBITS MESSENGER-RNA PRECURSOR SPLICING
The Journal of biological chemistry
EFFECT OF 5-FLUOROURACIL AND 5-BROMOURACIL SUBSTITUTION ON THE TRANSLATION OF HUMAN THYMIDYLATE SYNTHASE MESSENGER-RNA
The Journal of biological chemistry
DETECTION OF CLONAL T-CELL POPULATIONS IN GASTROINTESTINAL LYMPHOMAS BY ANALYSIS OF CRNA CONFORMATIONAL POLYMORPHISMS OF REARRANGED T-CELL-RECEPTOR-GAMMA GENES
British Journal of Haematology
ANALYSES OF P53 GENE-MUTATIONS IN PRIMARY HUMAN BLADDER-CANCER
Oncology research
DIFFERENTIAL S100-BETA EXPRESSION IN CHOROIDAL AND SKIN MELANOMAS - QUANTITATION BY THE POLYMERASE CHAIN-REACTION
Investigative ophthalmology & visual science
P53 GENE MUTATION IN PRIMARY HUMAN RENAL-CELL CARCINOMA
Oncology research